Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 2)

This publication has 34 references indexed in Scilit:

• Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 1)
  Drug Discovery Today, 2001
• Identification of a P-Glycoprotein-Deficient Subpopulation in the CF-1 Mouse Strain Using a Restriction Fragment Length Polymorphism
  Toxicology and Applied Pharmacology, 1997
• Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
  Proceedings of the National Academy of Sciences, 1997
• P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity
  Toxicology and Applied Pharmacology, 1997
• Comparisons of P‐glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta
  FEBS Letters, 1995
• In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier
  Biochemical Pharmacology, 1995
• In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier
  Biochemical Pharmacology, 1994
• Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
  Published by Elsevier ,1994
• P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
  Life Sciences, 1992